Why the study?
Is deep subcutaneous adipose tissue associated with metabolic syndrome and cardiometabolic risk factors in asymptomatic subjects?
Is deep subcutaneous adipose tissue associated with metabolic syndrome and cardiometabolic risk factors in asymptomatic subjects?
Deep subcutaneous adipose tissue is significantly associated with metabolic syndrome, increased inflammation, and oxidative stress, suggesting it functions similarly to visceral fat as a metabolically active compartment.
No takes yet. Share an insight, caveat, or question.
dSAT may flag higher MetS risk in asymptomatic adults; leaves open whether it improves risk stratification beyond visceral fat in prospective studies.
Kim et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: